Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011

Relief Therapeutics Holding SA / Key word(s): Research Update Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011 22-May-2025 / 07:00 CET/CEST Release of an ad hoc an…

Weiterlesen auf der Quellseite

Ähnliche Beiträge